Literature DB >> 10604977

Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area.

C J Swanson1, P W Kalivas.   

Abstract

Glutamatergic innervation of the ventral tegmental area (VTA) and the nucleus accumbens (NA) regulates locomotor activity. The present study was designed to evaluate the involvement of metabotropic glutamate receptors (mGluRs) in motor activity. Agonists selective for each of the three subgroups of mGluRs were microinjected into the VTA or NA, and motor activity was monitored. The group I agonist (S)-3,5-dihydroxyphenylglycine elicited a dose-dependent elevation in motor activity after microinjection into either the VTA or NA. The effect in the NA was blocked by the mGluR1-specific antagonist 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester. The group II agonist (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine also elicited a short-duration motor activation after microinjection into either structure. The dose response in the VTA was biphasic, and the coadministration of the group II/III-specific antagonist (RS)-alpha-methyl-4-phosphonophenylglycine partially blocked motor activation in both the NA and VTA. Although the group III agonist L-(+)-2-amino-4-phosphonobutyric acid produced a relatively modest behavioral stimulation after microinjection into the NA, it was without effect in the VTA. These data indicate a role for mGluR subgroups in the regulation of motor activity in the VTA and NA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10604977

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  27 in total

1.  Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors.

Authors:  M E Rhodes; C A Frye
Journal:  Cogn Affect Behav Neurosci       Date:  2001-09       Impact factor: 3.282

2.  Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway.

Authors:  Benjamin N Greenwood; Teresa E Foley; Tony V Le; Paul V Strong; Alice B Loughridge; Heidi E W Day; Monika Fleshner
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

3.  Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons.

Authors:  A Ledonne; A Nobili; E C Latagliata; V Cavallucci; E Guatteo; S Puglisi-Allegra; M D'Amelio; N B Mercuri
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

4.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

5.  Disinhibition of the Nucleus Accumbens Leads to Macro-Scale Hyperactivity Consisting of Micro-Scale Behavioral Segments Encoded by Striatal Activity.

Authors:  Dorin Yael; Orel Tahary; Boris Gurovich; Katya Belelovsky; Izhar Bar-Gad
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

6.  Role of mGluR5 neurotransmission in reinstated cocaine-seeking.

Authors:  Xiusong Wang; Khaled Moussawi; Lori Knackstedt; Haowei Shen; Peter W Kalivas
Journal:  Addict Biol       Date:  2012-02-17       Impact factor: 4.280

7.  Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer.

Authors:  C J Swanson; D A Baker; D Carson; P F Worley; P W Kalivas
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

8.  Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice.

Authors:  Yosuke Morishima; Tsuyoshi Miyakawa; Tomoyuki Furuyashiki; Yasuhiro Tanaka; Hiroshi Mizuma; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

9.  Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

Authors:  Nathalie Breysse; Christelle Baunez; Will Spooren; Fabrizio Gasparini; Marianne Amalric
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.